Snowball logo
logo
3009

Hubei Goto Biopharm Co.Ltd.

300966 SHE
¥26.71-¥0.47  (1.73%)
Estimate
EPS
-0.62
Beta
0.45
Growth
Revenue, YoY
16.32%
Net income, YoY
195.59%
FCF, YoY
76.63%
Dividends
Dividend yield
0.17%
Annual payout
¥0.05
Next ex. div date
July 16, 27
Div.rating
About the company
Ticker
300966
ISIN
Country
China
Sector (GICS)
Healthcare
Hubei Goto Biopharm Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of steroid drug raw materials in China and internationally. It offers starting materials, intermediates, and other pharmaceutical raw materials. The company was formerly known as Hubei Goto Biopharm Co.,Ltd. and changed its name to Hubei Goto Biopharm Group Co., Ltd. in June 2026. The company was founded in 2006 and is based in Xiangyang, China.

Frequently asked questions

What sector does Hubei Goto Biopharm Co.Ltd. (300966) operate in?

Hubei Goto Biopharm Co.Ltd. belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Hubei Goto Biopharm Co.Ltd. (300966) current stock price?

As of the latest data, Hubei Goto Biopharm Co.Ltd. stock price is CN¥26.71, with a previous close of CN¥27.18. Hubei Goto Biopharm Co.Ltd. lost -CN¥0.47 in the last trading session, representing a -1.73% loss.

What is Hubei Goto Biopharm Co.Ltd. (300966) current market capitalization?

Hubei Goto Biopharm Co.Ltd. market cap is approximately 3.08 billion.

What is Hubei Goto Biopharm Co.Ltd. (300966) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.62.

Does Hubei Goto Biopharm Co.Ltd. (300966) pay dividends?

Yes. Hubei Goto Biopharm Co.Ltd. pays annual dividends with an annualized yield of 0.17% and an estimated annual payout of CN¥0.05 per share.

When is the next ex-dividend date for Hubei Goto Biopharm Co.Ltd. (300966)?

The next ex-dividend date is scheduled for July 16, 2027.

What is Hubei Goto Biopharm Co.Ltd. (300966) beta (volatility) score?

Hubei Goto Biopharm Co.Ltd. has a beta of 0.450, indicating lower volatility than the overall market.